Fabian Willenborg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fabian Willenborg has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ashvinath Narenderan
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore
2 shared publications - Julius Fredens
NUS Synthetic Biology for Clinical and Technological Innovation, Yong Loo Lin School of Medicine, National University of Singapore, and National Centre for Engineering Biology, Singapore, Singapore
2 shared publications - Shujian Ong
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore
2 shared publications - Shuxuan Lao
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore
2 shared publications - Tobias V. Eden
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore
2 shared publications - Wen Shan Yew
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), 8 Medical Drive, Singapore 117597, Singapore
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (6) , 1585-1597
Bridging continuous and discrete evolution through a controllable, hypermutagenic phage-bacteria system
Directed evolution methods face trade-offs between the control of discrete approaches and the throughput of modern continuous systems. Here, we engineered a method called lytic selection and evolution (LySE) for near-continuous evolution of bacterial gene clusters while maintaining discrete checkpoints. We developed a hypermutagenic T7 DNA polymerase variant fused to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. By relieving pressure from maintaining genome fidelity, we obtained mutation rates of 3.82 × 10−5 substitutions per base. For biocontainment, the T7 DNA polymerase was encoded on an accessory plasmid, while the target gene cluster was encoded on a T7 DNA polymerase-lacking T7 phagemid. Alternating cycles of lysis and transduction enable selective replication and mutagenesis of target genes, while off-target genomic mutations are discarded. LySE evolved a 25-fold increase in tetA-encoded tigecycline resistance in 5 cycles, and a 50.9% increase in endpoint biomass of a bacterial strain that uses the polyethylene terephthalate monomer, ethylene glycol, as its sole carbon source. Our method balances speed and control for directed bacterial evolution.
- 1 May 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (6) , 1585-1597
Open AccessBridging continuous and discrete evolution through a controllable, hypermutagenic phage-bacteria system
Directed evolution methods face trade-offs between the control of discrete approaches and the throughput of modern continuous systems. Here, we engineered a method called lytic selection and evolution (LySE) for near-continuous evolution of bacterial gene clusters while maintaining discrete checkpoints. We developed a hypermutagenic T7 DNA polymerase variant fused to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. By relieving pressure from maintaining genome fidelity, we obtained mutation rates of 3.82 × 10−5 substitutions per base. For biocontainment, the T7 DNA polymerase was encoded on an accessory plasmid, while the target gene cluster was encoded on a T7 DNA polymerase-lacking T7 phagemid. Alternating cycles of lysis and transduction enable selective replication and mutagenesis of target genes, while off-target genomic mutations are discarded. LySE evolved a 25-fold increase in tetA-encoded tigecycline resistance in 5 cycles, and a 50.9% increase in endpoint biomass of a bacterial strain that uses the polyethylene terephthalate monomer, ethylene glycol, as its sole carbon source. Our method balances speed and control for directed bacterial evolution.
- Open Access
Genetic Code Expansion Facilitates Programmable Ubiquitylation via UBE2W
Deciphering the ubiquitin code requires homogenous, site-specifically ubiquitylated proteins, yet their access remains difficult. Current chemical and enzymatic methods are often limited by harsh conditions, low yields, or the introduction of non-native scars. Here, we present UbyW (Ubiquitylation by UBE2W), a chemoenzymatic platform that overcomes these hurdles. By repurposing the E2 enzyme UBE2W to target a genetically encoded non-canonical amino acid, a near-native Ub-protein conjugate is formed with high efficiency and site-specificity. The method is broadly applicable to diverse proteins, including those with structured domains, and can be performed in vitro or within a reconstituted cascade in living E. coli for streamlined production. Crucially, UbyW allows for the direct installation of bioorthogonal and photocrosslinking handles at the linkage site, providing powerful tools to probe the functional consequences of ubiquitylation and map ubiquitin-dependent interactomes.
Open AccessGenetic Code Expansion Facilitates Programmable Ubiquitylation via UBE2W
Deciphering the ubiquitin code requires homogenous, site-specifically ubiquitylated proteins, yet their access remains difficult. Current chemical and enzymatic methods are often limited by harsh conditions, low yields, or the introduction of non-native scars. Here, we present UbyW (Ubiquitylation by UBE2W), a chemoenzymatic platform that overcomes these hurdles. By repurposing the E2 enzyme UBE2W to target a genetically encoded non-canonical amino acid, a near-native Ub-protein conjugate is formed with high efficiency and site-specificity. The method is broadly applicable to diverse proteins, including those with structured domains, and can be performed in vitro or within a reconstituted cascade in living E. coli for streamlined production. Crucially, UbyW allows for the direct installation of bioorthogonal and photocrosslinking handles at the linkage site, providing powerful tools to probe the functional consequences of ubiquitylation and map ubiquitin-dependent interactomes.
- Open Access
Accelerated evolution of whole gene clusters by an engineered lytic phage system in E. coli
Directed evolution excels at optimizing individual proteins, but simultaneous evolution of multiple genes remains a significant challenge. Here, we establish a robust phage-based system for accelerated evolution of large gene clusters of up to 39 kilobases. Lytic Selection and Evolution (LySE) selectively replicates and mutagenizes the target gene cluster, carried on a phagemid through alternating cycles of lysis and transduction in Escherichia coli . We engineered a hypermutagenic T7 DNA polymerase (T7 DNAP) that increases mutation rates of the replicating phagemid 7,000-fold during the lytic cycle. We further optimized the mutational spectrum by fusing the T7 DNAP to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. LySE-mediated transduction enables selection for desired metabolic functions by coupling gene cluster expression to host fitness, while eliminating genomic off-target mutations by refreshing the host in each cycle. Using LySE, we evolved a 25-fold increase in tigecycline resistance in 5 cycles, and a 50.9% increase in end-point biomass of a bacterial strain that utilizes the PET monomer, ethylene glycol, as its sole carbon source.
Open AccessAccelerated evolution of whole gene clusters by an engineered lytic phage system in E. coli
Directed evolution excels at optimizing individual proteins, but simultaneous evolution of multiple genes remains a significant challenge. Here, we establish a robust phage-based system for accelerated evolution of large gene clusters of up to 39 kilobases. Lytic Selection and Evolution (LySE) selectively replicates and mutagenizes the target gene cluster, carried on a phagemid through alternating cycles of lysis and transduction in Escherichia coli . We engineered a hypermutagenic T7 DNA polymerase (T7 DNAP) that increases mutation rates of the replicating phagemid 7,000-fold during the lytic cycle. We further optimized the mutational spectrum by fusing the T7 DNAP to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. LySE-mediated transduction enables selection for desired metabolic functions by coupling gene cluster expression to host fitness, while eliminating genomic off-target mutations by refreshing the host in each cycle. Using LySE, we evolved a 25-fold increase in tigecycline resistance in 5 cycles, and a 50.9% increase in end-point biomass of a bacterial strain that utilizes the PET monomer, ethylene glycol, as its sole carbon source.